Product Reports Resources Pricing Login Book a demo

CeQur

Health Tech & Medtech · Horw, Switzerland · Founded 2008

Developing and commercializing simple drug delivery devices that can be easily integrated into daily life MoreLess

CeQur Simplicity is a medical device company specializing in innovative insulin delivery systems designed to improve diabetes management. The company serves individuals with diabetes who require mealtime insulin, offering a discreet, compact, and water-resistant patch that simplifies insulin administration. Operating in the healthcare and medical device market, CeQur Simplicity's business model revolves around the sale of its proprietary insulin delivery patches. Revenue is generated through direct sales to consumers and partnerships with healthcare providers. The product is clinically proven to reduce A1C levels and increase Time in Range (TIR), thereby minimizing long-term health complications associated with diabetes. The patch stays in place for up to three days, allowing users to maintain their insulin regimen with less interference and added convenience. CeQur Simplicity aims to ease the burden of multiple daily injections, replacing them with a single patch that delivers rapid-acting insulin with just one click. The company focuses on providing a user-friendly solution that enhances adherence to insulin therapy, ultimately improving patient outcomes.

Keywords: insulin delivery, diabetes management, medical device, A1C reduction, Time in Range, discreet patch, water-resistant, healthcare, patient adherence, mealtime insulin.

Company overview

CeQur company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2008
Headquarters
Horw, Switzerland
Employees
150
Open positions
None listed
Dealroom signal
90.5
client focusb2bclient focusb2ctechnologyHardwaretechnologyDeep TechtechnologyConnected Devicesub industryMedical DevicessectorDiabetesbusiness modelManufacturingindustryHealthsectorRemote MonitoringsectorMetabolismsectorWearablesectorTech for PatientssectorDigital Care

Valuation & funding

CeQur funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES EOther financing Jun 2026 $100M $600M Undisclosed
LATE VCOther financing Jan 2025 $120M $480M Undisclosed
SERIES COther financing Apr 2021 $115M $460M Tandem Diabetes Care · Federated Hermes · Ypsomed · GMS Capital
SERIES COther financing Sep 2015 $100M $400M Schroders · Endeavour Vision · Woodford Investment Management · Arthurian Life Sciences
SERIES BOther financing Sep 2013 $27M $108M Undisclosed
SERIES AOther financing Jan 2010 VI Partners · Schroders · Endeavour Vision
CORPORATE SPINOUTOther financing Dec 2008 Danfoss
Showing 7 recorded eventsUnlock the complete deal history →

Growth signals

CeQur website traffic

Latest recorded traffic for CeQur is 25K monthly website visits, down 35.9% over the last three months. CeQur's team grew 13.6% over the past year.

Latest monthly visits25K 3-month web change-35.9% 1-year team growth+13.6%
Monthly website visits131 observations · Oct 2014–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

CeQur compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

CeQur's talent

Book a demo to see the people
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on CeQur's cap table

Sourced from Dealroom's funding and investor records.

Series A 3 investors entered at this stage
VI Partners
Schroders
Endeavour Vision
Series B+ 9 investors entered at this stage
Danfoss
Woodford Investment Management
Arthurian Life Sciences
Credit Suisse Entrepreneur Capital
Tandem Diabetes Care
Federated Hermes
Ypsomed
GMS Capital
Kingdon Capital

Global footprint

Where CeQur has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States97.3%
🇨🇭 Switzerland2.7%
2 countries shown

In the news

Latest news about CeQur

Recent press, funding announcements, and product moves mentioning CeQur — open to read from the original sources.

See all news

Market sentiment

What the market is saying about CeQur

An AI-synthesized read of the highest-engagement posts about CeQur on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CeQur’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.